Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats
Identifieur interne : 000D52 ( Main/Exploration ); précédent : 000D51; suivant : 000D53Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats
Auteurs : Chun-Hung Lin ; Jui-Yen Huang [Taïwan] ; Cheng-Hsin Ching ; Jih-Ing Chuang [Taïwan]Source :
- Journal of Pineal Research [ 0742-3098 ] ; 2008-03.
English descriptors
Abstract
Abstract: Parkinson’s disease (PD) is a movement disorder resulting from nigrostriatal dopaminergic neurodegeneration. The impairment of mitochondrial function and dopamine synaptic transmission are involved in the pathogenesis of PD. Two mitochondrial inhibitors, 1‐methyl‐4‐phenylpyridine (MPP+) and rotenone, have been used to induce dopaminergic neuronal death both in in vitro and in vivo models of PD. Because the uptake of MPP+ is mediated by the dopamine transporter (DAT), we used a cell‐permeable rotenone‐induced PD model to investigate the role of DAT and dopamine D2 receptor (D2R) on dopaminergic neuronal loss. Rotenone subcutaneously infused for 14 days induced PD symptoms in rats, as indicated by reduced spontaneous locomotor activity (hypokinesis), loss of tyrosine hydroxylase (TH, a marker enzyme for dopamine neurons) immunoreactivity in the substantia nigra and striatum, obvious α‐synuclein accumulation, downregulated DAT protein expression, and upregulated D2R expression. Interestingly, rotenone also caused significant noradrenergic neuronal loss in the locus coeruleus. Melatonin, an antioxidant, prevented nigrostriatal neurodegeneration and α‐synuclein aggregation without affecting the rotenone‐induced weight loss and hypokinesis. However, rotenone‐induced hypokinesis was markedly reversed by the DAT antagonist nomifensine and body weight loss was attenuated by the D2R antagonist sulpiride. In addition, both antagonists significantly prevented the reduction of striatal TH or DAT immunoreactivity but not the loss of nigral TH‐ and DAT‐immunopositive neurons. These results suggested that oxidative stress and DAT downregulation are involved in the rotenone‐induced pathogenesis of nigrostriatal dopaminergic neurodegeneration, whereas D2R upregulation may simply represent a compensatory response.
Url:
DOI: 10.1111/j.1600-079X.2007.00510.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats</title><author><name sortKey="Lin, Chun Ung" sort="Lin, Chun Ung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name></author><author><name sortKey="Huang, Jui En" sort="Huang, Jui En" uniqKey="Huang J" first="Jui-Yen" last="Huang">Jui-Yen Huang</name></author><author><name sortKey="Ching, Cheng Sin" sort="Ching, Cheng Sin" uniqKey="Ching C" first="Cheng-Hsin" last="Ching">Cheng-Hsin Ching</name></author><author><name sortKey="Chuang, Jih Ng" sort="Chuang, Jih Ng" uniqKey="Chuang J" first="Jih-Ing" last="Chuang">Jih-Ing Chuang</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D967AC6756490C3C8F4A053BE0DD546C29358946</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1111/j.1600-079X.2007.00510.x</idno><idno type="url">https://api.istex.fr/document/D967AC6756490C3C8F4A053BE0DD546C29358946/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002C41</idno><idno type="wicri:Area/Main/Curation">002872</idno><idno type="wicri:Area/Main/Exploration">000D52</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats</title><author><name sortKey="Lin, Chun Ung" sort="Lin, Chun Ung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name><affiliation><wicri:noCountry code="no comma">Department of Physiology</wicri:noCountry></affiliation></author><author><name sortKey="Huang, Jui En" sort="Huang, Jui En" uniqKey="Huang J" first="Jui-Yen" last="Huang">Jui-Yen Huang</name><affiliation><wicri:noCountry code="no comma">Department of Physiology</wicri:noCountry></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan</wicri:regionArea><wicri:noRegion>Tainan</wicri:noRegion></affiliation></author><author><name sortKey="Ching, Cheng Sin" sort="Ching, Cheng Sin" uniqKey="Ching C" first="Cheng-Hsin" last="Ching">Cheng-Hsin Ching</name><affiliation><wicri:noCountry code="no comma">Department of Physiology</wicri:noCountry></affiliation></author><author><name sortKey="Chuang, Jih Ng" sort="Chuang, Jih Ng" uniqKey="Chuang J" first="Jih-Ing" last="Chuang">Jih-Ing Chuang</name><affiliation><wicri:noCountry code="no comma">Department of Physiology</wicri:noCountry></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country><wicri:regionArea>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan</wicri:regionArea><wicri:noRegion>Tainan</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Pineal Research</title><idno type="ISSN">0742-3098</idno><idno type="eISSN">1600-079X</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2008-03">2008-03</date><biblScope unit="volume">44</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="205">205</biblScope><biblScope unit="page" to="213">213</biblScope></imprint><idno type="ISSN">0742-3098</idno></series><idno type="istex">D967AC6756490C3C8F4A053BE0DD546C29358946</idno><idno type="DOI">10.1111/j.1600-079X.2007.00510.x</idno><idno type="ArticleID">JPI510</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0742-3098</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson’s disease</term><term>dopamine D2 receptor</term><term>dopamine transporter</term><term>melatonin</term><term>rotenone</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Parkinson’s disease (PD) is a movement disorder resulting from nigrostriatal dopaminergic neurodegeneration. The impairment of mitochondrial function and dopamine synaptic transmission are involved in the pathogenesis of PD. Two mitochondrial inhibitors, 1‐methyl‐4‐phenylpyridine (MPP+) and rotenone, have been used to induce dopaminergic neuronal death both in in vitro and in vivo models of PD. Because the uptake of MPP+ is mediated by the dopamine transporter (DAT), we used a cell‐permeable rotenone‐induced PD model to investigate the role of DAT and dopamine D2 receptor (D2R) on dopaminergic neuronal loss. Rotenone subcutaneously infused for 14 days induced PD symptoms in rats, as indicated by reduced spontaneous locomotor activity (hypokinesis), loss of tyrosine hydroxylase (TH, a marker enzyme for dopamine neurons) immunoreactivity in the substantia nigra and striatum, obvious α‐synuclein accumulation, downregulated DAT protein expression, and upregulated D2R expression. Interestingly, rotenone also caused significant noradrenergic neuronal loss in the locus coeruleus. Melatonin, an antioxidant, prevented nigrostriatal neurodegeneration and α‐synuclein aggregation without affecting the rotenone‐induced weight loss and hypokinesis. However, rotenone‐induced hypokinesis was markedly reversed by the DAT antagonist nomifensine and body weight loss was attenuated by the D2R antagonist sulpiride. In addition, both antagonists significantly prevented the reduction of striatal TH or DAT immunoreactivity but not the loss of nigral TH‐ and DAT‐immunopositive neurons. These results suggested that oxidative stress and DAT downregulation are involved in the rotenone‐induced pathogenesis of nigrostriatal dopaminergic neurodegeneration, whereas D2R upregulation may simply represent a compensatory response.</div></front></TEI><affiliations><list><country><li>Taïwan</li></country></list><tree><noCountry><name sortKey="Ching, Cheng Sin" sort="Ching, Cheng Sin" uniqKey="Ching C" first="Cheng-Hsin" last="Ching">Cheng-Hsin Ching</name><name sortKey="Lin, Chun Ung" sort="Lin, Chun Ung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name></noCountry><country name="Taïwan"><noRegion><name sortKey="Huang, Jui En" sort="Huang, Jui En" uniqKey="Huang J" first="Jui-Yen" last="Huang">Jui-Yen Huang</name></noRegion><name sortKey="Chuang, Jih Ng" sort="Chuang, Jih Ng" uniqKey="Chuang J" first="Jih-Ing" last="Chuang">Jih-Ing Chuang</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D967AC6756490C3C8F4A053BE0DD546C29358946
|texte= Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone‐induced parkinsonian rats
}}
| This area was generated with Dilib version V0.6.23. |  |